Response Biomedical Corp. - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Response Biomedical Corp.. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Response Biomedical Corp.. The Group's principal activity is to develops, manufactures and sells diagnostic tests for use with its proprietary RAMP System, a fluorescent immunoassay-based on-site diagnostic testing platform. The RAMP technology utilizes a unique method to account for sources of error inherent in conventional lateral flow immunoassay technologies, thereby providing the ability to quickly and accurately detect and quantify an analytic present in a liquid sample. It operates in the United States, Asia, Canada, Europe and other.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report